$1.38
arrow_drop_up7.81%Key Stats | |
---|---|
Open | $1.26 |
Prev. Close | $1.26 |
EPS | -1.32 |
Dividend | Non-Dividend |
Next Earnings Date | - |
Dividend Yield % | - |
Market Cap | $42.35M |
PE Ratio | - |
LOW | HIGH | |
---|---|---|
Day Range | 1.26 | 1.36 |
52 Week Range | 0.60 | 6.80 |
Ratios | |
---|---|
Revenue | - |
EBITDA Margin % | - |
EPS | -1.32 |
Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.
Period: Next 12 Months
•Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.
Reviva Pharmaceuticals Announces Pricing of $5.0 Million Underwritten Offering Priced At-the-Market Under Nasdaq Rules
Analyst Assessment On Reviva Pharmaceuticals' Positive Schizophrenia Trial Data - Sees More Than 200% Upside In Stock
Benzinga's Top Ratings Upgrades, Downgrades For September 20, 2023
Expert Ratings for Reviva Pharmaceuticals
Benzinga's Top Ratings Upgrades, Downgrades For June 8, 2023
Where Reviva Pharmaceuticals Stands With Analysts